Product logins

Find logins to all Clarivate products below.


Reprocessed Devices – United States – 2018

With the increasing movement toward value-based health care, effective population health management, and continued hospital consolidation, the competitive field among vendors is largely being driven by enhancing interoperability, workflow management integration, patient and imaging data analysis through artificial intelligence, and storage between the PACS, RIS, and CVIS/CPACS solutions. However, market saturation driving increased price competition among vendors, health care system budgetary constraints, and an increasing shift toward enterprise solutions will limit market growth to a significant degree. The market will also be negatively affected in the short term by the global COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PACS, RIS, and CVIS in the US across a 10-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Infusion Pumps – Market Insights – United States
The US infusion pumps market will be primarily driven by the introduction of new technologies and the adoption of innovative products. These advancements are expected to contribute to moderate…
Report
Obesity Interventions – Market Insights – United States
The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future…